Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men
- 30 April 1994
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 106 (2) , 139-147
- https://doi.org/10.1016/0021-9150(94)90119-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patientsDiabetes, 1993
- The status of PAI-1 as a risk factor for arterial and thrombotic disease: A reviewAtherosclerosis, 1992
- Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosisDiabetologia, 1991
- Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1Metabolism, 1990
- Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese womenMetabolism, 1989
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrationsJournal of the American College of Cardiology, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Plasminogen activator inhibitor in the blood of patients with coronary artery disease.BMJ, 1985
- A mathematical relationship between the fatty acid composition of the diet and that of the adipose tissue in manThe American Journal of Clinical Nutrition, 1980